Aminoacetonitrile/analogs & derivatives; Epilepsy, Reflex/drug therapy; MAP Kinase Signaling System/drug effects; Mitogen-Activated Protein Kinase 1/antagonists & inhibitors; Mitogen-Activated Protein Kinase 3/antagonists & inhibitors; Protein Kinase Inhibitors/therapeutic use; Acoustic Stimulation/adverse effects; Aminoacetonitrile/pharmacology; Aminoacetonitrile/therapeutic use; Animals; Brain/metabolism; CREB-Binding Protein/metabolism; Epilepsy, Reflex/enzymology; Epilepsy, Reflex/genetics; Exocytosis/drug effects; Female; Glutamic Acid/metabolism; MAP Kinase Signaling System/physiology; Male; Mitogen-Activated Protein Kinase 1/physiology; Mitogen-Activated Protein Kinase 3/physiology; Nerve Tissue Proteins/antagonists & inhibitors; Nerve Tissue Proteins/physiology; Protein Kinase Inhibitors/pharmacology; Protein Processing, Post-Translational/drug effects; Rats; Rats, Mutant Strains; Reaction Time/drug effects; Synapses/drug effects; Synapses/metabolism; Synapsins/metabolism; Synaptosomal-Associated Protein 25/metabolism; Vesicle-Associated Membrane Protein 2/metabolism; Vesicular Glutamate Transport Protein 2/biosynthesis; Vesicular Glutamate Transport Protein 2/genetics; gamma-Aminobutyric Acid/biosynthesis; gamma-Aminobutyric Acid/metabolism

SL 327; SNAP25; VAMP2; VGLUT2; synapsin I